Skip to main content
Explore URMC

URMC Logo

URMC / Research / Research@URMC
Prostate Cancer Danger Zone: More Likely for Older, Black Men

Prostate Cancer Danger Zone: More Likely for Older, Black Men

When prostate cancer is detected through a screening test and no symptoms are present, logic would say the disease is probably insignificant and the patient can avoid aggressive treatment. Yet statistics tell a different story: 1 in 6 of these men will have higher-risk disease, according to a University of Rochester study published in Frontiers in Oncology.

1/28/2014
Hematology Event Draws Wilmot Scientists, New Data

Hematology Event Draws Wilmot Scientists, New Data

Several members of the lymphoma and leukemia teams at the James P. Wilmot Cancer Center are to present research at the 55th annual American Society of Hematology (ASH) meeting, Dec. 7 to 10, which is attended by more than 20,000 clinicians and scientists.

12/5/2013
Lighting Up Brings Patients Down in Colorectal Surgery

Lighting Up Brings Patients Down in Colorectal Surgery

A study in the Annals of Surgery found that smoking boosts the risk of complications like infection and pneumonia after some of the most common colorectal procedures. Author Fergal Fleming, M.D., breaks down the risks in this video.  

9/24/2013
Study Reveals Reasons for Calls to Wilmot Cancer Center

Study Reveals Reasons for Calls to Wilmot Cancer Center

If you’re being treated for cancer and experiencing symptoms, what would cause you to pick up the phone and call your cancer center? Pain emerged as the number one reason, in a study of 563 patients, who reported 2,378 symptoms during 1,229 phone calls to the James P. Wilmot Cancer Center.

9/10/2013
URMC Virologists Lauded for Contribution to HPV Vaccine in New Book

URMC Virologists Lauded for Contribution to HPV Vaccine in New Book

William Bonnez, M.D., Richard Reichman, M.D., and Robert C. Rose, Ph.D. are featured in a Spanish book called 40 + 1 Innovators Who Have Changed the World of the 21st Century for their pioneering work on the human papillomavirus (HPV) vaccine. 

9/9/2013